Clinical Trials on DMMR Cancer in France

Total 5181 results

Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer (MONAMI)

MSI | dMMR Colorectal Cancer

France
Centre Leon Berard

Active, not recruiting

Immunotherapy in MSI/dMMR Tumors in Perioperative Setting. (IMHOTEP)

Localized Resectable Tumor | MSI/dMMR or EBV-positive Gastric Cancers

France
Centre Hospitalier le Mans

Recruiting

Painful and Barometric Dynamic Monitoring in the Aftermath of Foot Surgery Using the Distal Metatarsal Mini-invasive Osteotomy (DMMO) Method (BAROC)

Distal Metatarsal Mini-invasive Osteotomy (DMMO)

France
GERCOR - Multidisciplinary Oncology Cooperative...
Bristol-Myers Squibb

Recruiting

Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma. (NEONIPIGA)

Localized Oesogastric Adenocarcimona | MSI and or dMMR

France
Federation Francophone de Cancerologie Digestive

Recruiting

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer (SIRTCI)

Metastatic Colorectal Cancer | MSS | pMMR | Immune Checkpoint Inhibitor | Internal Radiotherapy

France
Novartis Pharmaceuticals

Recruiting

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers

Japan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
Centre Hospitalier Universitaire de Besancon

Completed

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients (TandHER)

Metastatic Cancer | HER2-positive Gastric Cancer | Docetaxel | Trastuzumab

France
UNICANCER
Pfizer; National Cancer Institute, France; Fondation ARC

Completed

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 (AcSé)

Metastatic Cancer | Solid Tumors | Hematologic Cancers

France
Centre Hospitalier Universitaire de Besancon

Unknown

Cohort Study to Assess Impact of Chemotherapy Plus Bevacizumab on Health Related Quality of Life in First Line Metastatic Colorectal Cancer (COBEQOL)

Quality of Life | Metastatic Colorectal Cancer

France
Daiichi Sankyo France

Recruiting

Safety, Effectiveness and Quality of Life of Trastuzumab Deruxtecan in Patients With HER2+ Breast Cancer

HER2-positive Breast Cancer

France
University Hospital, Rouen

Completed

Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation (PANEL)

Breast Cancer | Colorectal Cancer | Ovarian Cancer | Pediatric Cancers | Multiple Primary Malignant Tumours

France
Centre Hospitalier Universitaire de Besancon

Completed

IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA) (IMBASSA)

Breast Cancer | BRCA1 Mutation | BRCA2 Mutation

France
Centre Leon Berard
GlaxoSmithKline

Recruiting

PREventing Second Cancers With DOSTARlimab (PREDOSTAR)

Recurrent Cancer | Second Cancer | Primary Cancer

France
UNICANCER
Hoffmann-La Roche; National Cancer Institute, France; Fondation ARC

Active, not recruiting

Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations (AcSé)

Solid Tumors | Hematologic Cancers | Metastatic Cancers

France
Centre Hospitalier Universitaire de Besancon
Pfizer

Active, not recruiting

Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma (SURF)

Kidney Neoplasms | Metastatic Renal Cell Cancer

France
Centre Hospitalier de Cayenne

Completed

Cervical Cancer in French Guiana: Screening Between 2006-2011 (DepCol)

Cervical Cancer

France
Groupe Hospitalier Paris Saint Joseph

Completed

Securing and Optimizing the Patient's Drug Therapy With Cancer: Clinical Pharmacy and Articulation With the City (PRIMAC)

Cancer

France
Groupe Hospitalier Paris Saint Joseph

Terminated

Cancer and Sexual Health : Early Information and Sexual Satisfaction of Couples in Oncology (COUPLE)

Cancer

France
Centre Francois Baclesse
Ligue contre le cancer, France

Recruiting

Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase (AFTERGYN)

Long Term Cancer Side Effects | Supportive Care in Cancer | Cancer Survivorship Care Plan | Advanced Nurse Practitioner | Pelvic Gynecological Cancer

France
Hospices Civils de Lyon

Unknown

A Multicenter Phase II Pilot Open Label (BKM120)

Thyroid Cancers

France
Assistance Publique - Hôpitaux de Paris
MSD France

Active, not recruiting

Integrated Care Pathway in Oncology (PASSION) (PASSION)

Breast Cancer | Thoracic Neoplasms | Gastric Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Colon Cancer

France
Nantes University Hospital

Active, not recruiting

Status of Superficial Esophageal Cancers Treated by Endoscopy "OESOFARE" (OESOFARE)

Superficial Esophageal Cancers

France
Centre Hospitalier de la côte Basque

Recruiting

Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy (EQLVCPAL)

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Oesophageal Cancer | Hepatic Cancer | Biliary Cancer

France
Hospices Civils de Lyon

Recruiting

PITCHER (Peritoneal Carcinomatosis Heterogeneity)

Colorectal Cancer | Ovarian Cancer | Secondary Peritoneal Cancers

France
Centre Georges Francois Leclerc

Completed

Preoperative Chemo-radiation With IG-IMRT Dose Escalation for Locally Advanced Rectal Cancers (RADICAL)

Advanced Rectal Cancers

France
Hospices Civils de Lyon

Completed

The Use of Alternative Medicine by Palliative Care Patients

Cancer | Terminal Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Discovery of Microbiome-based Biomarkers for Patients With Cancer Using Metagenomic Approach (ONCOBIOTICS)

Cancer

France
Institut National de la Santé Et de la Recherche...

Recruiting

Memory Neuroimaging in Children, Adolescents and Young Adults Following Pediatric Cancer (IMPALA)

Pediatric Cancer | Cancer Brain

France
Institut Paoli-Calmettes
UNICANCER - Le Groupe génétique et cancer (GGC)

Recruiting

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation (GENEPSO)

Breast Cancers | Ovarian Cancers

France
University Hospital, Brest

Recruiting

Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of Patients (TADIG-P)

Cancer

France
University Hospital, Strasbourg, France

Recruiting

Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey (OnKO-TnT-1-0)

Cancer

France
GCS Ramsay Santé pour l'Enseignement et la Recherche

Not yet recruiting

Cancer and Literacy in Health (CaLiS)

Cancer

France
Centre Hospitalier Universitaire de Besancon

Recruiting

Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1 (ITHER)

Cancer

France
Direction Centrale du Service de Santé des Armées

Completed

After Cancer in the Military: What Happens After Long-term Sick Leave (APCAM-CLDM)

Cancer

France
Centre Henri Becquerel

Completed

Trimodal Imaging Before Radiotherapy (TRIMODAL)

Cancer

France
Centre Hospitalier Universitaire de Nīmes

Terminated

Impact of Multisensory Hand Massage on the Well-being of Cancer Patients (ONCOTACT)

Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Pharmacogenetics of VOD in Children With HSCT (MVO)

Cancer

France
Assistance Publique - Hôpitaux de Paris

Completed

Follow-up of Oncology Patients After Hospitalization in ICU (SALTO)

Cancer

France
Centre Antoine Lacassagne

Completed

Prospective Evaluation of Iron Status in Cancer Patients Beginning Chemotherapy (CANFER)

Cancer

France
Assistance Publique Hopitaux De Marseille

Completed

Nuclear Matrix and Cancer: Proteomic and Genomic Analyses Using Microarray in Cells Obtained Via Thoracocentesis

Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics (MONAGE)

Cancer

France
University Hospital, Toulouse

Not yet recruiting

E-Care Acceptability for Older People Undergoing Chemotherapy (ONCO-CHATBOT)

Cancer

France
Assistance Publique Hopitaux De Marseille

Recruiting

Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer. (SCHISM)

Cancer

France
Institut de cancérologie Strasbourg Europe

Completed

Study Comparing Satisfaction of Hospitalized Patients Receiving Invasive Care for Cancer Treatment, With Snoezelen Session Versus Standard Care (SNOEZELEN)

Cancer

France
Institut Claudius Regaud

Completed

Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer (IQversusMI)

Cancer

France
Centre Georges Francois Leclerc

Completed

Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic (canSEROcov)

Cancer

France
Groupe Hospitalier Mutualiste de Grenoble
Fondation de l'Avenir

Completed

Health Course of Patients Undergoing Per os Anti-cancer Therapy. (MinOS)

Cancer

France
Centre Oscar Lambret
Institut National de la Santé Et de la Recherche Médicale, France

Terminated

Preliminary Study to the Manufacturing of a Non-stick Membrane for Surgery Using Patient's Own Cells (MESO-PATCH) (MESO-PATCH)

Cancer

France
University Hospital, Caen
MSD France

Unknown

Oral Chemotherapy and Quality of Care (PARCOURS)

Cancer

France
Centre Antoine Lacassagne

Completed

Information Consultation by Radiotherapy Manipulator (INFORTH)

Cancer

France

3

Subscribe